Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China · Delayed Price · Currency is CNY 45.09
+0.49 (1.10%)
At close: Feb 13, 2026
SHA:688273 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 101.51 | 101.58 | 89.82 | 121.68 | 118.38 | 121.93 |
Depreciation & Amortization | 25.07 | 25.07 | 17.84 | 14.47 | 11.42 | 6.16 |
Other Amortization | 3.94 | 3.94 | 2.29 | 3.14 | 1.68 | 1.06 |
Loss (Gain) From Sale of Assets | 0.12 | 0.12 | -0.23 | 0 | -0.31 | -0 |
Asset Writedown & Restructuring Costs | 9.94 | 9.94 | - | - | - | 0.5 |
Loss (Gain) From Sale of Investments | -5.07 | -5.07 | -14.54 | -7.97 | -4.77 | -3.9 |
Provision & Write-off of Bad Debts | 0.81 | 0.81 | 0.45 | 2.84 | 0.55 | - |
Other Operating Activities | 11.98 | 8.93 | 3.71 | 8.33 | 1.75 | 0.15 |
Change in Accounts Receivable | -9.48 | -9.48 | 16.38 | -16.48 | 2.61 | -1.24 |
Change in Inventory | -16.13 | -16.13 | 16.09 | -31.03 | -18.04 | 3.14 |
Change in Accounts Payable | -1.54 | -1.54 | 3.37 | 23.09 | 32.14 | -1 |
Change in Other Net Operating Assets | -0.01 | -0.01 | 4.74 | 5.39 | 4.95 | 2.95 |
Operating Cash Flow | 125.48 | 122.51 | 136.91 | 126.67 | 148.6 | 131.1 |
Operating Cash Flow Growth | 7.68% | -10.52% | 8.08% | -14.75% | 13.35% | 25.49% |
Capital Expenditures | -135.16 | -129.71 | -75.15 | -54.26 | -14.58 | -25.91 |
Sale of Property, Plant & Equipment | 1.04 | 0.75 | 0.57 | 0.03 | 0.36 | 0.02 |
Cash Acquisitions | - | -17.29 | -10.5 | - | - | -1.99 |
Divestitures | 0.1 | - | - | - | - | - |
Investment in Securities | -153.45 | -347.4 | -166.58 | -40 | - | - |
Other Investing Activities | -10.26 | -14.42 | 14.23 | 7.93 | 5.5 | 3.39 |
Investing Cash Flow | -297.73 | -508.07 | -237.43 | -86.31 | -8.73 | -24.5 |
Short-Term Debt Issued | - | 7 | - | - | - | 16.08 |
Total Debt Issued | 8 | 7 | - | - | - | 16.08 |
Short-Term Debt Repaid | - | -6.73 | - | - | -7.34 | -25.02 |
Long-Term Debt Repaid | - | -10.89 | -4.44 | -6.96 | -3.06 | - |
Total Debt Repaid | -19.89 | -17.62 | -4.44 | -6.96 | -10.39 | -25.02 |
Net Debt Issued (Repaid) | -11.89 | -10.62 | -4.44 | -6.96 | -10.39 | -8.94 |
Issuance of Common Stock | - | - | 13.12 | 938.53 | - | 4.48 |
Repurchase of Common Stock | -33.78 | -33.78 | -18.47 | - | - | - |
Common Dividends Paid | -62.89 | -98.9 | -82.22 | -50 | -0.03 | -54.12 |
Other Financing Activities | 14.49 | -21.22 | 8.32 | -18.22 | -7.14 | -0.14 |
Financing Cash Flow | -94.07 | -164.52 | -83.69 | 863.34 | -17.57 | -58.72 |
Foreign Exchange Rate Adjustments | -0.01 | 0.02 | 0.01 | 0.01 | - | - |
Net Cash Flow | -266.32 | -550.07 | -184.21 | 903.71 | 122.3 | 47.87 |
Free Cash Flow | -9.68 | -7.2 | 61.76 | 72.41 | 134.01 | 105.18 |
Free Cash Flow Growth | - | - | -14.71% | -45.97% | 27.41% | 78.93% |
Free Cash Flow Margin | -2.21% | -1.70% | 18.12% | 19.21% | 39.23% | 31.26% |
Free Cash Flow Per Share | -0.10 | -0.07 | 0.62 | 0.87 | 1.79 | 1.40 |
Cash Income Tax Paid | 34.82 | 32.2 | 41.1 | 22.65 | 37.03 | 34.68 |
Levered Free Cash Flow | -72.99 | -41.98 | 24.83 | 21.54 | 76.5 | 46.35 |
Unlevered Free Cash Flow | -72.14 | -41.31 | 25.06 | 21.72 | 76.59 | 46.63 |
Change in Working Capital | -22.82 | -22.82 | 37.58 | -15.82 | 19.89 | 5.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.